Madhu Pudipeddi
Senior Vice President of Technical OperationsDr. Madhu Pudipeddi, Ph.D., serves as Senior Vice President of Technical Operations at Prelude Therapeutics Incorporated since 2021. Prior to joining Prelude, Dr. Madhu Pudipeddi was an Executive Director at Novartis Pharmaceuticals, where Madhu Pudipeddi had roles of increasing responsibility for many years in the areas of drug development and technical operations. Dr. Pudipeddi contributed to the development and commercialization of several new molecular entities, build-up of an R&D organization in India, and oversaw Manufacturing Science & Technology operations in Europe and Americas. Prior to joining Novartis, Dr. Pudipeddi was at Bristol-Myers Squibb where he was engaged in drug discovery-development collaboration and development of new molecular entities. Dr. Pudipeddi received his B.S. in Pharmaceutical Sciences from Andhra University, India and his Ph.D. in Pharmaceutical Sciences from the University of Wisconsin, Madison.
Positions
- Company NamePrelude Therapeutics IncorporatedStock CodePRLDPositionSenior Vice President of Technical OperationsColleagues
- KVKrishna VaddiFounder, CEO & Director
- PAPaul A. FriedmanIndependent Chairman of the Board
- BDBryant David LimCFO, Chief Legal Officer & Corporate Secretary
- PAPeggy A. ScherleChief Scientific Officer
- ACAimee CrombieSenior VP and Head of Strategic Planning & Operations
- DBDavid BonitaIndependent Director
- VSVictor SandorIndependent Director
- KDKatina DortonIndependent Directors
